Credit Suisse’s Boston Scientific BSX Stock Holding History

Credit Suisse’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-297,300	Closed	-$12.6M	–	3680
2021 Q4	$12.6M	Buy	+297,300	New	+$12.5M	0.01%	1333
2021 Q2	–	Sell	-239,200	Closed	-$9.24M	–	4454
2021 Q1	$9.24M	Sell	239,200 -350,500	-59%	-$13.3M	﹤0.01%	1633
2020 Q4	$21.2M	Buy	589,700 +568,400	+2,669%	+$20.5M	0.01%	1138
2020 Q3	$814K	Buy	+21,300	New	+$821K	﹤0.01%	3080
2020 Q2	–	Sell	-114,500	Closed	-$3.74M	–	3963
2020 Q1	$3.74M	Buy	+114,500	New	+$4.47M	﹤0.01%	1722
2019 Q3	–	Sell	-30,000	Closed	-$1.29M	–	4113
2019 Q2	$1.29M	Buy	30,000 +10,000	+50%	+$385K	﹤0.01%	2765
2019 Q1	$768K	Buy	+20,000	New	+$764K	﹤0.01%	3090
2018 Q4	–	Sell	-60,000	Closed	-$2.31M	–	3875
2018 Q3	$2.31M	Buy	+60,000	New	+$2.1M	﹤0.01%	2253
2018 Q1	–	Sell	-343,800	Closed	-$8.52M	–	3968
2017 Q4	$8.52M	Buy	343,800 +188,900	+122%	+$5.21M	0.01%	1390
2017 Q3	$4.52M	Buy	+154,900	New	+$4.28M	﹤0.01%	1842

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's BSX Position: Q1 2024 in Review

Credit Suisse reduced its Boston Scientific (BSX) stake by 3% in Q1 2024, selling an estimated $4.04M and leaving 2,058,101 shares worth $141M. The position accounts for 0.13% of the portfolio, ranked #142.

Credit Suisse first reported a position in BSX in Q2 2013 and has held it in 44 quarters since. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

Credit Suisse held 2,058,101 shares of Boston Scientific worth $141M as of Q1 2024.
Credit Suisse sold 62,865 Boston Scientific shares in Q1 2024, an estimated $4.04M.
Boston Scientific made up 0.13% of Credit Suisse's portfolio in Q1 2024, its #142 holding.
Credit Suisse first reported a position in Boston Scientific in Q2 2013 and has held it in 44 quarters since.
1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.